No CrossRef data available.
Article contents
Reinfection Incidences in Health Care Workers and Non-Health Care Workers: A Single-Center Study in a Turkish SARS-CoV-2 Patient Cohort
Published online by Cambridge University Press: 07 July 2025
Abstract
Background
The COVID-19 pandemic, which has killed millions of people worldwide, continues to be marked by waves of reinfections. We aimed to assess the incidence and clinical characteristics of reinfection in COVID- 19 cohort.
Material and Methods
A single-center descriptive study was conducted. Data were collected from all patients who tested positive for SARS-CoV-2 via PCR from March 18, 2020, the onset of the first major COVID-19 wave, until the end of 2020. All PCR-positive patients were followed-up, and those who had SARS-CoV-2 PCR positivity again at least 90 days after the initial onset were contacted via telemedicine.
Results
5814 patients diagnosed with COVID-19 with PCR positive in the first wave were included. The incidence of reinfection among the cohort of patients infected with SARS-CoV-2 during the initial wave of COVID-19 was 0.73%. Among healthcare workers, the 1-year reinfection rate was 2.14%, 3.9 times higher than non-healthcare workers. We observed that the clinical course was milder and less complicated in patients who had reinfection. In cases of reinfection among fully vaccinated individuals, statistically significantly fewer symptoms were observed.
Conclusions
We observed that healthcare workers are at approximately four times greater risk of reinfection. Reinfections generally presented with a milder clinical course.
Information
- Type
- Research Letters
- Information
- Copyright
- © The Author(s), 2025. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc
References
European Centre for Disease Prevention and Control E. Reinfection with SARS-CoV-2: Considerations for Public Health Response 2020. https://www.ecdc.europa.eu/sites/default/files/documents/Re-infection-and-viral-shedding-threat-assessment-brief.pdfGoogle Scholar
Yahav, D, Yelin, D, Eckerle, I, et al. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. 2021;27(3):315–318. doi:10.1016/j.cmi.2020.11.028.CrossRefGoogle ScholarPubMed
CDC Centers for Disease Control and Prevention. Investigative Criteria for Suspected Cases of SARS-CoV-2 Reinfection (ICR). National Center for Immunization and Respiratory Diseases (US). Division of Viral Diseases.Google Scholar
Ukwishaka, J, Ndayishimiye, Y, Destine, E, et al. Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis. BMC Public Health. 2023;23(1):778. doi:10.1186/s12889-023-15626-7CrossRefGoogle ScholarPubMed
To, KK, Hung, IF, Ip, JD, et al. Coronavirus Disease 2019 (COVID-19) re-infection by a phylogenetically distinct Severe Acute Respiratory Syndrome Coronavirus 2 strain confirmed by whole genome sequencing. Clin Infect Dis. 2021;73(9):e2946–e2951. doi:10.1093/cid/ciaa1275.CrossRefGoogle ScholarPubMed
Qureshi, AI, Baskett, WI, Huang, W, et al. Reinfection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in patients undergoing serial laboratory testing. Clin Infect Dis. 2022;74(2):294–300. doi:10.1093/cid/ciab345.CrossRefGoogle ScholarPubMed
Hansen, CH, Michlmayr, D, Gubbels, SM, et al. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet. 2021;397(10280):1204–1212. doi:10.1016/S0140-6736(21)00575-4CrossRefGoogle ScholarPubMed
Hall, VJ, Foulkes, S, Charlett, A, et al. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). Lancet. 2021;397(10283):1459–1469. doi:10.1016/S0140-6736(21)00675-9.CrossRefGoogle Scholar
Bongiovanni, M, Marra, AM, Bini, F, et al. COVID-19 reinfection in healthcare workers: a case series. J Infect. 2021;82(6):e4–e5. doi:10.1016/j.jinf.2021.04.002CrossRefGoogle ScholarPubMed
Lewis, N, Chambers, LC, Chu, HT, et al. Effectiveness associated with vaccination after COVID-19 recovery in preventing reinfection. JAMA Netw Open. 2022;5(7):e2223917. Published 2022 Jul 1. doi:10.1001/jamanetworkopen.2022.23917CrossRefGoogle ScholarPubMed
Flacco, ME, Acuti Martellucci, C, Baccolini, V, et al. Risk of reinfection and disease after SARS-CoV-2 primary infection: meta-analysis. Eur J Clin Invest. 2022;52(10):e13845. doi:10.1111/eci.13845CrossRefGoogle ScholarPubMed
Murillo-Zamora, E, Trujillo, X, Huerta, M, et al. Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk. BMC Infect Dis. 2021;21(1):923. doi:10.1186/s12879-021-06643-1CrossRefGoogle ScholarPubMed
Rivelli, A, Fitzpatrick, V, Blair, C, et al. Incidence of COVID-19 reinfection among Midwestern healthcare employees. PLoS One. 2022;17(1):e0262164. Published 2022 Jan 4. doi:10.1371/journal.pone.0262164CrossRefGoogle ScholarPubMed
Mensah, AA, Lacy, J, Stowe, J, et al. Disease severity during SARS-COV-2 reinfection: a nationwide study. J Infect. 2022;84(4):542–550. doi:10.1016/j.jinf.2022.01.012CrossRefGoogle ScholarPubMed
de Arriba Fernández, A, Bilbao, JLA, Francés, AE, et al. Evaluation of persistent COVID and SARS-CoV-2 reinfection in a cohort of patients on the island of Gran Canaria, Spain. Semergen. 2023;49(5):101939. doi:10.1016/j.semerg.2023.101939CrossRefGoogle Scholar